Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Tricida, Inc.
*STREET
7000 Shoreline Court, Suite 201
*CITY
South San Francisco
*STATE
(Required for U.S. applicants)
California
*COUNTRY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
94080
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
pharmaceutical preparations for the treatment of metabolic acidosis associated with chronic kidney disease; pharmaceutical preparations for
the treatment of renal diseases and disorders; pharmaceutical preparations for increasing bicarbonate levels; non-absorbed pharmaceutical preparations, namely, pharmaceutical preparations for the
treatment of metabolic acidosis and renal disorders; polymeric pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of metabolic acidosis and renal disorders
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88595076
Filing Date:08/27/2019
To the Commissioner for Trademarks:
MARK: VAZARIS (Standard Characters, see mark)
The literal element of the mark consists of VAZARIS. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Tricida, Inc., a corporation of Delaware, having an address of
7000 Shoreline Court, Suite 201
South San Francisco, California 94080
United States
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: pharmaceutical preparations for the treatment of metabolic acidosis associated with chronic kidney disease; pharmaceutical preparations for the treatment of renal
diseases and disorders; pharmaceutical preparations for increasing bicarbonate levels; non-absorbed pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of metabolic
acidosis and renal disorders; polymeric pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of metabolic acidosis and renal disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The applicant hereby appoints Katherine A. Keating. Other appointed attorneys are Katherine Green. Katherine A. Keating of Bryan Cave Leighton Paisner LLP, is a member of the XX bar, admitted to
the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
Three Embarcadero Center, 7th Floor
San Francisco, California 94111
United States
415-675-3400(phone)
415-675-3434(fax)
katherine.keating@bclplaw.com (authorized).
The attorney docket/reference number is 1080298.67.
Katherine A. Keating submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any
U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
Email Authorization: I authorize the USPTO to send email correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the
email address provided in this application. I understand that a valid email address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Edward J. Hejlek/ Date: 08/27/2019
Signatory's Name: Edward J. Hejlek
Signatory's Position: General Counsel & Sr. VP
Payment Sale Number: 88595076
Payment Accounting Date: 08/27/2019
Serial Number: 88595076
Internet Transmission Date: Tue Aug 27 17:52:13 EDT 2019
TEAS Stamp: USPTO/BAS-XXX.XX.XX.XX-20190827175213153
198-88595076-610641b3088629f954b9f5b744b
e59371d4bc13f719a63ee7469c2dfb1f4b91d4-D
A-52131595-20190827151345726928